Pfizer pulls batches of antibiotic in Australia over anaphylaxis risk

By Gareth Macdonald contact

- Last updated on GMT


Related tags: Active pharmaceutical ingredient, Pharmaceutical drug, Pharmacology

Pfizer has recalled 10 batches of gentamicin in Australia because of problems with an API supplied by a third party.

Pfizer began the recall this month​ according to the Australian Therapeutic Goods Administration (TGA).

The agency said, “It has been identified that the affected batches of gentamicin injection may contain higher than expected amounts of histamine​.”

"Histamine injected intravenously or intramuscularly can potentially lead to signs and symptoms of hypersensitivity reactions, including severe allergic reaction​," it added.

A Pfizer representative confirmed the recall, telling us, “During a recent internal investigation Pfizer has identified that select batches of Gentamicin Injection BP 80 mg in 2 mL Steriluer may contain higher than expected histamine levels.​”

This is the result of an issue with the active product ingredient provided by a third party supplier​,” she said. The spokesperson declined to name the active pharmaceutical ingredient (API) manufacturer involved.

Pfizer said the recall would not affect the availability of the drug in Australia.

Histamine issues

Gentamicin is a generic version of the injectable antibiotic Garamycin, which was developed by Schering-Plough (which is now owned by Merck & Co).  

It is used to treat serious and potentially life-threatening infections and is on the World Health Organisation’s (WHO) list of essential medicines.

Pfizer is not the only drug firm that has recalled Gentamicin due to problems with the API in recent months.

In July​, Health Canada announced that Novartis’ generics unit Sandoz had pulled 12 batches of its version of the antibiotic.

Sandoz said it had found “histamine contamination in three Active Pharmaceutical Ingredient (API) batches​” used to make its product.

Related news

Show more

Related products

How to resolve sticking issues in tablet production

How to resolve sticking issues in tablet production

I Holland Limited - Tabletting Science | 24-Jun-2019 | Case Study

Tablet sticking is one of the most common problems in tablet manufacture. Find out how I Holland used the TSAR scientific predictive model and expert tablet...

How to measure powder and granule flow properties

How to measure powder and granule flow properties

Stable Micro Systems | 01-Apr-2019 | Technical / White Paper

Being able to predict, optimise and control powder flow is of prime importance to manufacturers in ensuring high quality standards. Download this free...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us


View more